tirzepatide and bupropion RETRACTED ARTICLE: Effect of combined GLP-1 analogue bupropion/naltrexone on weight loss: a retrospective cohort study Pharmacological Management of Obesity According

GLP-1s are becoming a bigger part of weight management

Dispose of used syringes in accordance with local regulations

In markets like India, where reimbursement is not expected, OOP will remain the only viable route, reinforcing the need for tailored strategies across geographies

Study: TripleHormone Receptor Agonist Retatrutide for Obesity (Phase 2 Trial, NEJM) Drug: Retatrutide a triple agonist (GLP-1, GIP, and glucagon receptors) Key Findings: Up to 28.7% mean weight loss at higher doses Marked improvements in insulin sensitivity and cardiometabolic risk factors Weight loss approaching outcomes seen with bariatric surgery, without surgery What makes Retatrutide unique is its triple-hormone mechanism, simultaneously targeting appetite regulation, energy expenditure, and glucose metabolism

GOLO DIET FOR BEGINNERS: The Definitive step by step guide on how to promote a healthy living, lose weight and decrease blood sugar level with the Golo diet